Fragment screen against ABLE
Correy, G.J., Fraser, J.S.To be published.
Experimental Data Snapshot
| Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image | 
| De novo designed ABLE protein | 126 | synthetic construct | Mutation(s): 0  |  | |
| Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| Sequence AnnotationsExpand | |||||
| 
 | |||||
| Ligands 1 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| CLW Query on CLW | B [auth A] | CHLORZOXAZONE C7 H4 Cl N O2 TZFWDZFKRBELIQ-UHFFFAOYSA-N | |||
| Length ( Å ) | Angle ( ˚ ) | 
|---|---|
| a = 26.452 | α = 90 | 
| b = 47.355 | β = 103.63 | 
| c = 46.404 | γ = 90 | 
| Software Name | Purpose | 
|---|---|
| PHENIX | refinement | 
| Aimless | data scaling | 
| PDB_EXTRACT | data extraction | 
| XDS | data reduction | 
| PHASER | phasing | 
| Funding Organization | Location | Grant Number | 
|---|---|---|
| National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) | United States | GM145238 |